Início › Câncer de Bexiga › Arizona
Ensaios clínicos de Câncer de Bexiga em Arizona
20 estudos para Câncer de Bexiga estão buscando participantes em locais em Arizona.
Cidades em Arizona
Texto oficial do estudo (Inglês)
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
- Banner MD Anderson Cancer Center, Gilbert
- Mayo Clinic Hospital in Arizona, Phoenix
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT07000084Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Kingman Regional Medical Center, Kingman
- Cancer Center at Saint Joseph's, Phoenix
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
Idades de 40 a 75 · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT05334069Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
- Banner University Medical Center - Tucson, Tucson
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT06770582Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
- Banner MD Anderson Cancer Center, Gilbert
- Mayo Clinic Hospital in Arizona, Phoenix
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT07061964Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Mayo Clinic Hospital in Arizona, Phoenix
- Mayo Clinic in Arizona, Scottsdale
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT03866382A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
- City of Hope Cancer Center-Phoenix, Goodyear
- Mayo Clinic Arizona, Phoenix
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT07277413DESTINY-PANTUMOUR04
- Research Site, Bullhead City
- Research Site, Casa Grande
RecrutandoEstudo observacional
Idades de 18 a 130 · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT07124000A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
- The University of Arizona Cancer Center - North Campus, Tucson
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07218380Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
- Banner MD Anderson Cancer Center, Gilbert
- Arizona Cancer Center at UMC North/University Medical Center, Tucson
RecrutandoFase 1/2
Idades de 18 a 99 · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT06814496ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- Ironwood Cancer & Research Centers, Chandler
RecrutandoEstudo observacional
Idades 18 e acima · Todos os sexos · Atualizado em 14 de set. de 2026 · NCT05059444Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
- Banner MD Anderson Cancer Center, Gilbert
- Mayo Clinic Arizona, Phoenix
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 3 de set. de 2026 · NCT06567743Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
- Mayo Clinic, Phoenix
- East Valley Urology Center of Arizona, Queen Creek
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 24 de ago. de 2026 · NCT05951179Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer
- East Valley Urology Center of Arizona, Queen Creek
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 21 de ago. de 2026 · NCT07480356FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
- University of Arizona - Cancer Center, Tucson
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 20 de ago. de 2026 · NCT05614739LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
- Mayo Clinic, Scottsdale
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 7 de ago. de 2026 · NCT04752722Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
- Local Institution - 0167, Gilbert
RecrutandoFase 2/3
Idades 18 e acima · Todos os sexos · Atualizado em 29 de jul. de 2026 · NCT07106762A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
- Banner Gateway Medical Center, Gilbert
- Banner MD Anderson Cancer Center, Gilbert
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 22 de jul. de 2026 · NCT04879329A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
- HonorHealth Research Institute, Scottsdale
- The University of Arizona Cancer Center, Tucson
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 13 de fev. de 2026 · NCT06778863Blue Light Cystoscopy With Cysview® Registry
- Mayo Clinic, Phoenix
RecrutandoEstudo observacional
Idades 18 e acima · Todos os sexos · Atualizado em 18 de dez. de 2025 · NCT02660645SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Scottsdale
RecrutandoEstudo observacional
Todas as idades · Todos os sexos · Atualizado em 28 de out. de 2025 · NCT03452774Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.